Cisplatin and hypokalemia

Author: jsdb

August undefined, 2024

WebKey Points. When evaluating hypokalemia, use the history to explore possible losses (renal vs. GI), shifts (pH, insulin, etc.), and intake. Get a full medication history. Then use the … WebJun 2, 2024 · Background: Cisplatin-associated acute kidney injury (C-AKI) is common. Predictive factors of C-AKI include age > 60 years, hypertension, cisplatin dose, diabetes, and serum albumin < 3.5g/L. The association between C-AKI and hypokalemia, hypomagnesemia or hyponatremia has not been well characterized to date.

DRUG NAME: Cisplatin - BC Cancer

WebSep 1, 2024 · Cisplatin for injection can cause severe hypersensitivity reactions, including anaphylaxis and death. Manifestations have included facial edema, wheezing, tachycardia, and hypotension. Hypersensitivity reactions have occurred within minutes of administration to patients with prior exposure toCisplatin for injection. t78o

A Clinician’s Guide to Inpatient Electrolyte Replacement

Webis a major concern when prescribing cisplatin. Renal dysfunction due to cisplatin may manifest as renal insufficiency, hypokalemia and hypomagnesemia. The risk for these … http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Head%20and%20Neck/HNLAPRT_Protocol.pdf WebCisplatin is a common cause of hypomagnesemia and hypokalemia due to renal magnesium (Mg) and potassium (K) losses. Magnesium plays an important role in the … t7a xfly

Cisplatin and hypokalemia

Electrolyte disorders with platinum-based chemotherapy: mechanisms ...

WebApr 1, 2024 · Triple disorder with metabolic alkalosis, metabolic acidosis, and respiratory alkalosis Compensated metabolic alkalosis Analyzing an acid-base disturbance is a 5-step process. Step 1: Look at the pH. Our patient’s arterial pH was 7.55, which, being higher than 7.45, shows a state of alkalemia. WebHypokalemia may develop with furosemide, especially with brisk diuresis, inadequate oral electrolyte intake, when cirrhosis is present, or during concomitant use of corticosteroids, ACTH, licorice in large amounts, or prolonged use of laxatives. ... There is a risk of ototoxic effects if cisplatin and furosemide are given concomitantly. In ...

Did you know?

WebThe Radiation Therapy Oncology Group launched a phase III trial to test the hypothesis that adding cetuximab to the radiation-cisplatin platform improves progression-free survival (PFS).Patients and methodsEligible patients with stage III or IV HNC were randomly assigned to receive radiation and cisplatin without (arm A) or with (arm B) cetuximab. Web8 mg PO/IV 30 to 60 minutes pre- CISplatin, then 8 mg PO/IV every 12 hours x 6 doses aprepitant . 125 mg PO 30 to 60 minutes pre-CISplatin on day 1, then 80 mg PO daily …

WebDec 17, 2024 · Hypokalemia is defined as a serum or plasma potassium that is less than the normal value. Most reference laboratories establish the lower pediatric limit of normal serum potassium between 3 and 3.5 mEq/L. However, symptoms are unlikely to occur in most healthy children until serum potassium is below 3 mEq/L. WebMar 5, 2014 · Cisplatin is a coordinate metal complex with significant antineoplastic activity, and its side effects include acute and chronic renal insufficiency, renal magnesium …

Webactivity of cisplatin [see Clinical Pharmacology (12.1), Clinical Studies (14)]. • Administer PEDMARK 6 hours after completion of a cisplatin infusion. • For multiday cisplatin regimens, administer PEDMARK 6 hours after completion of each cisplatin infusion and at least 10 hours before the next cisplatin infusion. Do not WebApr 12, 2024 · AKI-related cisplatin may also be associated with tubulopathies, such as Fanconi-like syndrome, hypomagnesemia, salt-loosing syndrome and distal renal tubular acidosis . Tubular dysfunction is characterized by electrolyte disorders such as hyponatremia, hypokalemia and hypomagnesemia.

WebThere is no relationship between the presence or severity of Cisplatin side effects and effectiveness of cisplatin. The following side effects are common(occurring in greater than 30%) for patients taking Cisplatin: Nausea and vomiting. Nausea may last up …

Web21 hours ago · The EARLY-MYO-BC trial is the first to explore the cardiac impacts of pyrotinib in the neoadjuvant setting for this patient population. Patients are currently … t791 craWebFirst-line multiagent chemotherapy comprises doxorubicin, cisplatin, and high-dose methotrexate (MAP regimen) . ... Regarding toxicity, rash and hypokalemia was the most common grade 3 adverse event, and one death from end organ failure was reported that was possibly related to the drug. t7a9n asicsWebMay 18, 2024 · Impaired kidney function is a relatively common complication of amphotericin B, as are other kidney manifestations, including urinary potassium wasting and hypokalemia, urinary magnesium wasting and hypomagnesemia, metabolic acidosis due to type 1 (or distal) renal tubular acidosis (RTA), and polyuria due to nephrogenic diabetes … t7a-ewWebMar 24, 2024 · Case 1: A case of hyponatremia following cisplatin chemotherapy A 64 year-old man with small cell lung cancer was treated with cisplatin chemotherapy with etoposide and concurrent chest radiotherapy. Serum sodium was 137 mmol/L prior to initiation of chemotherapy. t7asw b40 1r00 b102WebJun 1, 2024 · Hypomagnesemia and hypokalemia are side effects of certain chemotherapies, including cisplatin, cetuximab, eribulin, and ifosfamide. When patients concurrently receive chemotherapy and take medications that cause hypomagnesemia or hypokalemia, electrolyte imbalances are amplified. t7clx1 aircraftWebMedications that cause RTA include Cisplatin and Amphotericin B. You may have hypokalemia from a loss of body fluids due to excessive vomiting, diarrhea, or … t7an.com 9123WebJul 22, 2024 · Cisplatin is a potent and valuable chemotherapy agent used to treat a broad spectrum of malignancies. Renal tubular dysfunction and a cumulative … t7dr a pdf